GREM1 and malignant colon neoplasm: GREM1-mediated angiogenesis (potentially via VEGFR2 singalling) has been identified in pancreateic neuroendocrine tumors (Chen et al. 2013), colon cancer (Liu et al. 2019) and diffuse intrinsic pontine glioma (Shaik et al., 2017).